Literature DB >> 13572936

Clinical evaluation of miradon.

G KELLAWAY.   

Abstract

Keywords:  CORONARY DISEASE/therapy; MYOCARDIAL INFARCT/therapy; PHENINDIONE/related compounds; THROMBOSIS/therapy

Mesh：

Substances：

Year:  1958        PMID： 13572936      PMCID： PMC2026790          DOI： 10.1136/bmj.2.5101.889

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  14 in total

1.  Studies on the anticoagulant phenindione. II. Details regarding its administration in two hundred cases.

Authors:  C G GUTTAS; W C MOLONEY; H S SISE
Journal:  Am Heart J       Date:  1957-01       Impact factor: 4.749

2.  Studies on the anticoagulant phenylindanedione. I. The effect of emulsified vitamin K1 on phenylindanedione-induced hypoprothrombinemia.

Authors:  C G GUTTAS; W C MOLONEY; H S SISE
Journal:  Blood       Date:  1953-03       Impact factor: 22.113

3.  The control of prothrombin activity with tromexan therapy.

Authors:  M WEINER; G SIMSON; J J BURNS; J M STEELE; B B BRODIE
Journal:  Am J Med       Date:  1953-06       Impact factor: 4.965

4.  A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.

Authors:  L A SCARRONE; D F BECK; I S WRIGHT
Journal:  Circulation       Date:  1952-10       Impact factor: 29.690

5.  Tromexan in the treatment of coronary thrombosis.

Authors:  J A TULLOCH; A R GILCHRIST
Journal:  Am Heart J       Date:  1951-12       Impact factor: 4.749

6.  Preliminary report on the clinical use of a new anticoagulant, phenylindandione.

Authors:  A U BLAUSTEIN; J J CROCE; M ALBERIAN; N RICHEY
Journal:  Circulation       Date:  1950-05       Impact factor: 29.690

7.  Clinical experience with coumarin anticoagulants warfarin and warfarin sodium.

Authors:  D V CLATANOFF; P O TRIGGS; O O MEYER
Journal:  AMA Arch Intern Med       Date:  1954-08

8.  The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.

Authors:  B B BRODIE; M WEINER; J J BURNS; G SIMSON; E K YALE
Journal:  J Pharmacol Exp Ther       Date:  1952-12       Impact factor: 4.030

9.  An evaluation of a new anticoagulant, acenocoumarin (sintrom).

Authors:  M JIMINEZ; I KATZKA; M WEINER
Journal:  Circulation       Date:  1956-03       Impact factor: 29.690

10.  Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.

Authors:  R BOURGAIN; M TODD; L HERZIG; I S WRIGHT
Journal:  Circulation       Date:  1954-11       Impact factor: 29.690
View more
  1 in total

1.  Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration.

Authors:  J de Vries; C N Verboom; E J Groot; W T Nauta; E Wattel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.